Therefore, it is conceivable that although COVID-19 patients may have significantly higher TSP-1 levels than matched sedentary healthy controls two years after the acute following the infection, the lower levels of TSP-1 they exhibited could be due to impaired platelet activation [54]. The gene discussed is THBS1; the disease is COVID-19.